Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877)

Market Cap	24.27B
Revenue (ttm)	1.98B
Net Income (ttm)	-2.00B
Shares Out	984.87M
EPS (ttm)	-2.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	313,600
Open	11.70
Previous Close	11.76
Day's Range	11.58 - 11.84
52-Week Range	9.17 - 21.70
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 28, 2025

About Shanghai Junshi Biosciences

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 2,568
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1877

Financial Performance

In 2023, Shanghai Junshi Biosciences's revenue was 1.50 billion, an increase of 3.38% compared to the previous year's 1.45 billion. Losses were -2.28 billion, -4.38% less than in 2022.

Financial numbers in CNY